Skip to main content
SpringerLink
Log in

Neuroleptic-induced parkinsonism is associated with olfactory dysfunction

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Objective

There is increasing evidence for olfactory deficits in patients with extrapyramidal disorders, but little is known about their occurrence in patients with drug-induced extrapyramidal symptoms (EPS). The present study was performed to investigate olfactory function in depressed patients with drug-induced parkinsonism under treatment with D2-blocking neuroleptic drugs compared to depressed controls on similar neuroleptic dose without EPS (no-EPS), and neuroleptic-naive depressed controls (no-NL).

Methods

A total of 79 depressed patients with (N = 59) and without psychotic features (N = 20) were included in the study. Psychotic patients were treated with D2 blocking neuroleptic drugs. Of the neuroleptic-treated patients, 15 developed EPS. In all patients psychophysical olfactory testing was performed using “Sniffin’ Sticks” which included assessment of odor thresholds for phenylethylalcohol (PEA), odor identification, and odor discrimination.

Results

Patients in the EPS group had significantly lower olfactory scores than patients in the no-EPS or no-NL groups. Patients in the no-NL and no-EPS groups were not significantly different from each other in terms of olfactory function. Using partial correlations controlling for the patients’ age, significant correlations were observed for EPS patients between severity of EPS and odor thresholds and odor identification, but not for odor discrimination. This indicated that olfactory function decreased with increasing severity of EPS symptoms.

Conclusions

Our data show that olfactory deficits may be drug-induced in patients with primary affective disorder with a sensitivity toward developing EPS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91(4):247–250

    PubMed  CAS  Google Scholar 

  2. Hummel T, Jahnke U, Sommer U, Reichmann H, Muller A (2005) Olfactory function in patients with idiopathic Parkinson’s disease: effects of deep brain stimulation in the subthalamic nucleus. J Neural Transm 112(5):669–676

    Article  PubMed  CAS  Google Scholar 

  3. Muller A, Mungersdorf M, Reichmann H, Strehle G, Hummel T (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9(5):521–524

    Article  PubMed  CAS  Google Scholar 

  4. Muller A, Reichmann H, Livermore A, Hummel T (2002) Olfactory function in idiopathic Parkinson’s disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm 109(5–6):805–811

    Article  PubMed  CAS  Google Scholar 

  5. Hawkes C (2006) Olfaction in neurodegenerative disorder. Adv Otorhinolaryngol 63:133–151

    PubMed  Google Scholar 

  6. Serby M, Larson P, Kalkstein D (1991) The nature and course of olfactory deficits in Alzheimer’s disease. Am J Psychiatry 148(3):357–360

    PubMed  CAS  Google Scholar 

  7. Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, et al. (2006) Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 21(12):2062–2067

    Article  PubMed  Google Scholar 

  8. Demarquay G, Ryvlin P, Royet JP (2007) Olfaction and neurological diseases: a review of the literature. Rev Neurol (Paris) 163(2):155–167

    Article  PubMed  CAS  Google Scholar 

  9. Mueller A, Reuner U, Landis B, Kitzler H, Reichmann H, Hummel T (2006) Extrapyramidal symptoms in Wilson’s disease are associated with olfactory dysfunction. Mov Disord 21(9):1311–1316

    Article  PubMed  Google Scholar 

  10. Mena MA, de Yebenes JG (2006) Drug-induced parkinsonism. Expert Opin Drug Saf 5(6):759–771

    Article  PubMed  CAS  Google Scholar 

  11. Wei CJ, Linster C, Cleland TA (2006) Dopamine D(2) receptor activation modulates perceived odor intensity. Behav Neurosci 120(2):393–400

    Article  PubMed  CAS  Google Scholar 

  12. Kruzich PJ, Grandy DK (2004) Dopamine D2 receptors mediate two-odor discrimination and reversal learning in C57BL/6 mice. BMC Neurosci 5:12

    Article  PubMed  Google Scholar 

  13. Hegg CC, Lucero MT (2004) Dopamine reduces odor- and elevated-K(+)-induced calcium responses in mouse olfactory receptor neurons in situ. J Neurophysiol 91(4):1492–1499

    Article  PubMed  CAS  Google Scholar 

  14. Gottfried JA (2006) Smell: central nervous processing. Adv Otorhinolaryngol 63:44–69

    PubMed  Google Scholar 

  15. Hawkes C (2004) Olfactory testing in parkinsonism. Lancet Neurol 3(7):393–394

    Article  PubMed  Google Scholar 

  16. American Psychiatric Association (1996) Diagnostic and Statistical Manual of Mental Disorders. 4th edition ed. Washington, DC: American Psychiatric Press

  17. Serby M, Larson P, Kalkstein D (1990) Olfactory sense in psychoses. Biol Psychiatry 28(9):830

    Article  PubMed  CAS  Google Scholar 

  18. Sirota P, Davidson B, Mosheva T, Benhatov R, Zohar J, Gross-Isseroff R (1999) Increased olfactory sensitivity in first episode psychosis and the effect of neuroleptic treatment on olfactory sensitivity in schizophrenia. Psychiatry Res 86(2):143–153

    Article  PubMed  CAS  Google Scholar 

  19. Moberg PJ, McGue C, Kanes SJ, Roalf DR, Balderston CC, Gur RE, et al. (2007) Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance. Schizophr Res 90(1–3):221–228

    Article  PubMed  Google Scholar 

  20. Moberg PJ, Arnold SE, Doty RL, Gur RE, Balderston CC, Roalf DR, et al. (2006) Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. J Clin Exp Neuropsychol 28(8):1444–1461

    Article  PubMed  Google Scholar 

  21. Schneider F, Habel U, Reske M, Toni I, Falkai P, Shah NJ (2007) Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives. Psychiatry Res 155(2):103–112

    Article  PubMed  Google Scholar 

  22. Good KP, Whitehorn D, Rui Q, Milliken H, Kopala LC (2006) Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms. Am J Psychiatry 163(5):932–933

    Article  PubMed  Google Scholar 

  23. Hamilton M (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23:56–62

    Article  CAS  Google Scholar 

  24. Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ (2002) Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord 17(5):867–876

    Article  PubMed  Google Scholar 

  25. Benkert O, Hippius H (2006) Kompendium der Psychiatrischen Pharmacotherapie. 6. ed. Stuttgart, New York, Rome: Springer

  26. Hummel T, Kobal G, Gudziol H, Kay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264(3):237–243

    Article  PubMed  CAS  Google Scholar 

  27. Hummel T, Konnerth CG, Rosenheim K, Kobal G (2001) Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 110(10):976–981

    PubMed  CAS  Google Scholar 

  28. Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L (1984) Smell identification ability: changes with age. Science 226(4681):1441–1443

    Article  PubMed  CAS  Google Scholar 

  29. Keck PE Jr, McElroy SL, Havens JR, Altshuler LL, Nolen WA, Frye MA, et al. (2003) Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr Psychiatry 44(4):263–269

    Article  PubMed  Google Scholar 

  30. Pause BM, Miranda A, Goder R, Aldenhoff JB, Ferstl R (2001) Reduced olfactory performance in patients with major depression. J Psychiatr Res 35(5):271–277

    Article  PubMed  CAS  Google Scholar 

  31. Pollatos O, Albrecht J, Kopietz R, Linn J, Schoepf V, Kleemann AM, et al. (2007) Reduced olfactory sensitivity in subjects with depressive symptoms. J Affect Disord 102(1–3):101–108

    Article  PubMed  Google Scholar 

  32. Gross-Isseroff R, Luca-Haimovici K, Sasson Y, Kindler S, Kotler M, Zohar J (1994) Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder. Biol Psychiatry 35(10):798–802

    Article  PubMed  CAS  Google Scholar 

  33. Postolache TT, Wehr TA, Doty RL, Sher L, Turner EH, Bartko JJ, et al. (2002) Patients with seasonal affective disorder have lower odor detection thresholds than control subjects. Arch Gen Psychiatry 59(12):1119–1122

    Article  PubMed  Google Scholar 

  34. Plailly J, Radnovich AJ, Sabri M, Royet JP, Kareken DA (2007) Involvement of the left anterior insula and frontopolar gyrus in odor discrimination. Hum Brain Mapp 28(5):363–372

    Article  PubMed  Google Scholar 

  35. Bourin M, Lambert O, Guitton B (2005) Treatment of acute mania – from clinical trials to recommendations for clinical practice. Psychopharmacol 20(1):15–26

    Article  CAS  Google Scholar 

  36. Woodward ND, Purdon SE, Meltzer HY, Zald DH (2007) A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizophr Res 89(1–3):211–224

    Article  PubMed  Google Scholar 

  37. Nasrallah HA, Churchill CM, Hamdan-Allan GA (1988) Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Am J Psychiatry 145(11):1455–1456

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Psychiatry and Psychotherapy, Charité University Medicine Berlin, Campus Mitte, Berlin, Germany

    Stephanie Krüger

  2. Smell & Taste Clinic, Dept. of Otorhinolaryngology, University of Dresden Medical School, Fetscherstr. 74, 01307, Dresden, Germany

    Antje Haehner M.D., Claudia Thiem & Thomas Hummel

Authors
  1. Stephanie Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antje Haehner M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claudia Thiem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas Hummel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antje Haehner M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krüger, S., Haehner, A., Thiem, C. et al. Neuroleptic-induced parkinsonism is associated with olfactory dysfunction. J Neurol 255, 1574–1579 (2008). https://doi.org/10.1007/s00415-008-0993-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0993-5

Key words

Search

Navigation